Published in TB and Outbreaks Week, September 18th, 2001
C. Mawer and colleagues with Medical Emergency Relief International, London, compared standard Russian anti-TB regimens with the WHO-endorsed treatment in 646 new cases presenting to the two largest TB diagnostic and treatment centers in Tomsk Oblast, western Siberia.
Patients were at least 18 years old and were assigned to receive traditional Russian treatments (n=356, 155 smear-positive) or WHO short-course...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.